References
- Leone A, Simonetti F, Avvedimento M, Angellotti D, Immobile Molaro M, Franzone A, et al. Ultrathin struts drug-eluting stents: a state-of-the-art review. J Pers Med. 2022;12:13–78.
- Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, et al. Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial. EuroIntervention 2018;14:1207–14.
- Stojkovic S, Neskovic AN, Mehmedbegovic Z, Kafedzic S, Ostojic M, Nedeljkovic M, et al. Reduced sirolimus systemic exposure and improved bioresorbable polymer properties: new allies for the treatment of patients with coronary artery disease. Fund Clin Pharmacol. 2015;29:95–05.
- Valdes-Chavarri M, Kedev S, Neskovic AN, de la Tassa CM, Zivkovic M, Nouche RT, et al. Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the master study. EuroIntervention 2019;14:1836–42.
- Byrne RA, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J Acute Cardiovasc Care 2024;13:55–161.
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation 2018;138:618–51.
- Khosravani-Rudpishi M, Joharimoghadam A, Rayzan E. The significant coronary tortuosity and atherosclerotic coronary artery disease; What is the relation? J Cardiovasc Thorac Res. 2018;10:209–13.
- Ishibashi S, Sakakura K, Asada S, Taniguchi Y, Jinnouchi H, Tsukui T, et al. Angiographic coronary calcification: A simple predictor of long-term clinical outcomes in patients with acute myocardial infarction. J Atheroscler Thromb. 2023;30:990–1001.
- Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: The Academic Research Consortium-2 consensus document. Circulation 2018;137:2635–50.
- Suzuki N, Asano T, Nakazawa G, Aoki J, Tanabe K, Hibi K, et al. Clinical expert consensus document on quantitative coronary angiography from the Japanese association of cardiovascular intervention and therapeutics. Cardiovasc Interv Th. 2020;35:105–16.
- Jiménez VA, Iñiguez A, Baz JA, Valdés M, Ortiz A, Vuilliomenet A, et al. A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The Century II high risk ACS substudy. Cardiovasc Revasc Med. 2016;17:355–61.
- Gherbesi E, Danzi GB. The Ultimaster coronary stent system: 5-year worldwide experience. Future Cardiol. 2020;16:251–61.
- Buiten RA, Ploumen EH, Zocca P, Doggen CJ, Van Der Heijden LC, Kok MM, et al. Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: a prespecified analysis of the randomized bio-resort trial. JAMA Cardiol. 2019;14:659–69.
- Iglesias JF, Heg D, Roffi M, Tüller D, Noble S, Muller O, et al. Long-term effect of ultrathin-strut versus thin-strut drug-eluting stents in patients with small vessel coronary artery disease undergoing percutaneous coronary intervention: a subgroup analysis of the BIOSCIENCE randomized trial. Circ Cardiovasc Interv. 2019;12:80–24.
- Pilgrim T, Piccolo R, Heg DH, Roffi M, Tüller D, Vuilliomenet A, et al. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction. EuroIntervention 2016;12:1343–54.
- Kang S-H, Chung W-Y, Lee JM, Park J-J, Yoon C-H, Suh J-W, et al. Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial. EuroIntervention 2017;12:1623–31.
- Windecker S, Haude M, Neumann F-J, Stangl K, Witzenbichler B, Slagboom T, et al. Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. Circ Cardiovasc Interv. 2015;8:14–41.
- Sabate M, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. The Lancet 2012;380:1482–90.